Summary by Moomoo AI
Conge Pharmaceuticals Holdings Limited (CMS) conducted a series of share repurchases from April 2 to 12, 2024, but did not write them off. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose these changes. During this period, the company repurchased a total of 9,300,000 shares of common stock, representing 0.3793% of its issued shares. The last repurchase took place on April 12, 2024, and 1,050,000 shares were repurchased on the same day, priced between HKD 7.21 and HKD 7.35 for a total cost of HKD 7,642,680. The Company confirms that all repurchases have been approved by the Board of Directors and meet the requirements of the relevant Listing Rules.